Labcorp Holdings Inc

詳細情報 Labcorp Holdings Inc 企業名

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.

企業情報

企業コードLH

会社名Labcorp Holdings Inc

上場日Apr 24, 1991

設立日2024

最高経営責任者「CEO」Mr. Adam H. Schechter

従業員数70000

証券種類Ordinary Share

決算期末Apr 24

本社所在地358 S Main St

都市BURLINGTON

証券取引所NYSE Consolidated

国United States of America

郵便番号27215

電話番号13362291127

ウェブサイトhttps://www.labcorp.com/

企業コードLH

上場日Apr 24, 1991

設立日2024

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Adam H. Schechter

Chairman of the Board, President, Chief Executive Officer

98.96K

-5.81%

Dr. Brian J. Caveney, M.D., J.D.

Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer

30.07K

-6.24%

Mr. Lance V. Berberian

Executive Vice President - Special Advisor, Strategy

22.53K

+9.59%

Mr. Peter M. Neupert

Independent Director

12.89K

--

Dr. Garheng Kong, M.D., Ph.D.

Lead Independent Director

12.84K

--

Ms. Kerrii B. Anderson, CPA

Independent Director

12.67K

-3.80%

Ms. Richelle P. Parham

Independent Director

9.48K

--

Ms. Amy B. Summy

Executive Vice President, Chief Marketing Officer

5.30K

+16.66%

Mr. Mark S. Schroeder

Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer

4.96K

--

Mr. Akinbolade Oyegunwa

Executive Vice President and Chief Information and Technology Officer

3.46K

+16.48%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Adam H. Schechter

Chairman of the Board, President, Chief Executive Officer

98.96K

-5.81%

Dr. Brian J. Caveney, M.D., J.D.

Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer

30.07K

-6.24%

Mr. Lance V. Berberian

Executive Vice President - Special Advisor, Strategy

22.53K

+9.59%

Mr. Peter M. Neupert

Independent Director

12.89K

--

Dr. Garheng Kong, M.D., Ph.D.

Lead Independent Director

12.84K

--

Ms. Kerrii B. Anderson, CPA

Independent Director

12.67K

-3.80%

収益内訳

通貨: USD更新時刻: Wed, Mar 12

FY2021

FY2020

FY2019

データなし

地域別USD

会社名

収益

比率

Northern America

13.09B

81.22%

Europe

2.05B

12.72%

Other Countries

976.40M

6.06%

事業別

地域別

データなし

株主

更新時刻: Fri, May 16

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

11.57%

BlackRock Institutional Trust Company, N.A.

5.50%

State Street Global Advisors (US)

4.57%

Select Equity Group, L.P.

2.65%

Geode Capital Management, L.L.C.

2.47%

Other

73.23%

株主統計

比率

The Vanguard Group, Inc.

11.57%

BlackRock Institutional Trust Company, N.A.

5.50%

State Street Global Advisors (US)

4.57%

Select Equity Group, L.P.

2.65%

Geode Capital Management, L.L.C.

2.47%

Other

73.23%

種類

株主統計

比率

Investment Advisor/Hedge Fund

45.41%

Investment Advisor

41.39%

Research Firm

3.23%

Pension Fund

2.08%

Hedge Fund

1.82%

Bank and Trust

1.44%

Sovereign Wealth Fund

1.31%

Individual Investor

0.39%

Insurance Company

0.06%

Other

2.88%

機関投資家保有株

更新時刻: Mon, Jan 20

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q1

1833

81.30M

97.13%

-4.60M

2024Q4

1872

81.10M

96.90%

-5.32M

2024Q3

1856

80.09M

95.55%

-6.82M

2024Q2

1876

81.29M

96.43%

-7.49M

2024Q1

1904

82.39M

97.73%

-8.65M

2023Q4

1947

83.11M

99.02%

-9.76M

2023Q3

1930

84.34M

99.29%

-7.18M

2023Q2

1934

84.05M

94.75%

-3.56M

2023Q1

1940

82.33M

92.89%

-5.93M

2022Q4

1948

82.50M

93.48%

-7.69M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

9.62M

11.49%

+15.33K

+0.16%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

4.55M

5.43%

-7.51K

-0.16%

Dec 31, 2024

State Street Global Advisors (US)

3.70M

4.43%

-23.02K

-0.62%

Dec 31, 2024

Select Equity Group, L.P.

1.60M

1.91%

+959.98K

+150.95%

Dec 31, 2024

Geode Capital Management, L.L.C.

2.00M

2.4%

+39.26K

+2.00%

Dec 31, 2024

Allspring Global Investments, LLC

1.92M

2.29%

+51.05K

+2.74%

Dec 31, 2024

Diamond Hill Capital Management Inc.

1.97M

2.35%

-11.59K

-0.59%

Dec 31, 2024

BlackRock Financial Management, Inc.

1.92M

2.3%

-131.53K

-6.40%

Dec 31, 2024

Nordea Funds Oy

1.05M

1.26%

+68.97K

+7.01%

Dec 31, 2024

Fidelity Management & Research Company LLC

1.21M

1.45%

+30.98K

+2.62%

Dec 31, 2024

詳細を見る

関連ETF

更新時刻: Fri, Jun 6

銘柄名

比率

iShares U.S. Healthcare Providers ETF

3.67%

iShares Large Cap Value Active ETF

2.99%

Thrivent Small-Mid Cap ESG ETF

2.25%

SPDR S&P Health Care Services ETF

2.1%

Strategas Global Policy Opportunities ETF

2.02%

Knowledge Leaders Developed World ETF

1.99%

iShares Health Innovation Active ETF

1.93%

Invesco S&P 500 Equal Weight Health Care ETF

1.77%

Brandes US Value ETF

1.58%

First Trust Health Care Alphadex Fund

1.46%

詳細を見る

iShares U.S. Healthcare Providers ETF

比率3.67%

iShares Large Cap Value Active ETF

比率2.99%

Thrivent Small-Mid Cap ESG ETF

比率2.25%

SPDR S&P Health Care Services ETF

比率2.1%

Strategas Global Policy Opportunities ETF

比率2.02%

Knowledge Leaders Developed World ETF

比率1.99%

iShares Health Innovation Active ETF

比率1.93%

Invesco S&P 500 Equal Weight Health Care ETF

比率1.77%

Brandes US Value ETF

比率1.58%

First Trust Health Care Alphadex Fund

比率1.46%

配当金

過去5年間の配当金総支払額は 692.30M 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Jan 09, 2025

LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 12, 2025 going ex on Feb 27, 2025

Feb 27, 2025

Mar 12, 2025

Feb 27, 2025

Oct 10, 2024

LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 13, 2024 going ex on Nov 26, 2024

Nov 26, 2024

Dec 13, 2024

Nov 26, 2024

Jul 25, 2024

LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 13, 2024 going ex on Aug 29, 2024

Aug 29, 2024

Sep 13, 2024

Aug 29, 2024

Apr 11, 2024

LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 12, 2024 going ex on May 24, 2024

May 28, 2024

Jun 12, 2024

May 24, 2024

Jan 12, 2024

LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 13, 2024 going ex on Feb 26, 2024

Feb 27, 2024

Mar 13, 2024

Feb 26, 2024

Oct 12, 2023

LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 12, 2023 going ex on Nov 07, 2023

Nov 08, 2023

Dec 12, 2023

Nov 07, 2023

Jul 13, 2023

LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 08, 2023 going ex on Aug 07, 2023

Aug 08, 2023

Sep 08, 2023

Aug 07, 2023

Apr 06, 2023

LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 08, 2023 going ex on May 17, 2023

May 18, 2023

Jun 08, 2023

May 17, 2023

Jan 12, 2023

LH.NB Interim Cash Dividend of gross USD 0.72 paid on Mar 13, 2023 going ex on Feb 22, 2023

Feb 23, 2023

Mar 13, 2023

Feb 22, 2023

Oct 12, 2022

LH.NB Final Cash Dividend of gross USD 0.72 paid on Dec 09, 2022 going ex on Nov 16, 2022

Nov 17, 2022

Dec 09, 2022

Nov 16, 2022

詳細を見る

株式分割

日付

種類

比率

データなし

日付

種類

比率

データなし

258.700USD

Labcorp Holdings Inc

258.700

概要

企業名